Trial NCT02599649

View at ClinicalTrials.gov 
Org. Study IDs: 2014-0934
Secondary IDs: NCI-2015-02120

Last trial update was posted on 2020-01-14

MeSH Interventions

Azacitidine Nivolumab

MeSH Conditions

Myelodysplastic Syndromes Preleukemia

Other Conditions

Leukemia

Stopping Reasons

Enrollment was stopped after the sponsor's decision not to pursue the development of lirilumab for myeloid malignancies.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID